July 2021 FDA Recall Drug by Baycare Integrated Service Center, Llc /dba Baycare Central Pharmacy
D-0702-2021 - Lack of sterility assurance
This Class II drug recall was voluntarily initiated by Baycare Integrated Service Center, Llc /dba Baycare Central Pharmacy on July 30, 2021 for the product Drug. The FDA reported the reason for recall as lack of sterility assurance. The product was distributed in FL and the recall is currently terminated.
Recall Number: D-0702-2021
Lack of sterility assurance
07-30-2021
08-11-2021
253 syringes
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
FL
10-22-2021
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Succinylcholine Chloride 100 mg/5 mL (20 mg/mL), 5 mL Syringes, Rx only, For IV Use only, BayCare Central Pharmacy, 7802 E. Telecom Parkway, Temple Terrace, FL 33837
Batch or Lot Expiration Information
Lot# Lot: SUCC10020210624 Exp. 09/22/2021
